2.79
price up icon1.45%   0.04
after-market 시간 외 거래: 2.80 0.010 +0.36%
loading

Inovio Pharmaceuticals Inc (INO) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-06-30 2025-03-31 2024-06-30 2024-03-31 2023-12-31
기간 3개월 3개월 3개월 3개월 3개월
Revenues
100.00%
-
0.0653 0.1008 - 0.1027
Operating Expenses
8.09%
23.08
25.12 33.30 31.48 27.50
Benefits Costs and Expenses
-
- - - 25.11
Costs And Expenses
8.09%
23.08
25.12 33.30 31.48 25.11
Operating Income/Loss
7.85%
-23.08
-25.05 -33.20 -31.48 -27.39
Income/Loss From Continuing Operations Before Tax
19.42%
-23.52
-19.69 0.1008 -30.47 -25.00
Income/Loss From Continuing Operations After Tax
19.42%
-23.52
-19.69 -32.24 -30.47 -24.97
Net Income/Loss
19.42%
-23.52
-19.69 -32.24 -30.47 -25.00
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.56%
38.83
38.61 27.20 23.29 -241.67
Diluted Average Shares
0.56%
38.83
38.61 27.20 23.29 -241.67
Basic Earnings Per Share
19.61%
-0.61
-0.51 -1.19 -1.31 -5.67
Diluted Earnings Per Share
19.61%
-0.61
-0.51 -1.19 -1.31 -5.67
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
자본화:     |  볼륨(24시간):